Considerations in Preparative Regimen Selection to Minimize Rejection in Pediatric Hematopoietic Transplantation in Non-Malignant Diseases.

Frontiers in Immunology
Robert J Hayashi

Abstract

The variables that influence the selection of a preparative regimen for a pediatric hematopoietic stem cell transplant procedure encompasses many issues. When one considers this procedure for non-malignant diseases, components in a preparative regimen that were historically developed to reduce malignant tumor burden may be unnecessary. The primary goal of the procedure in this instance becomes engraftment with the establishment of normal hematopoiesis and a normal immune system. Overcoming rejection becomes the primary priority, but pursuit of this goal cannot neglect organ toxicity, or post-transplant morbidity such as graft-versus-host disease or life threatening infections. With the improvements in supportive care, newborn screening techniques for early disease detection, and the expansion of viable donor sources, we have reached a stage where hematopoietic stem cell transplantation can be considered for virtually any patient with a hematopoietic based disease. Advancing preparative regiments that minimize rejection and transplant related toxicity will thus dictate to what extent this medical technology is fully utilized. This mini-review will provide an overview of the origins of conditioning regimens for transplantation an...Continue Reading

References

May 25, 1999·Bone Marrow Transplantation·F RosalesA Nagler
Dec 10, 1999·Pediatric Transplantation·J E Sanders
Mar 29, 2000·Bone Marrow Transplantation·I DalalC M Roifman
May 29, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Donald BeamMaria L Escolar
Dec 18, 2007·Bone Marrow Transplantation·C Díaz de HerediaJ Sánchez de Toledo
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andrea BacigalupoMary Horowitz
Dec 2, 2010·Blood·Mitchell SabloffMark C Walters
Jul 14, 2012·Blood·Amel HassanUNKNOWN Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and European Society for Immunodefici
Jul 31, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Brandon M TriplettWing Leung
Jan 26, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Holly R MartinMaria L Escolar
Sep 21, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Divya T KouraLeslie S Kean
Oct 29, 2013·Lancet·Tayfun GüngörUNKNOWN Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation
Jun 11, 2014·Blood·Boglarka Gyurkocza, Brenda M Sandmaier
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Matthew M HsiehJohn F Tisdale
Jul 31, 2014·The New England Journal of Medicine·Sung-Yun PaiRichard J O'Reilly
Nov 12, 2014·Rambam Maimonides Medical Journal·Israel Henig, Tsila Zuckerman
Jan 18, 2015·The Journal of Allergy and Clinical Immunology·Claudia WehrUNKNOWN Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immuno
Jan 27, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John T HoranKuang-Yueh Chiang
Feb 25, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mieke AldenhovenJaap Jan Boelens
Mar 11, 2015·Pediatric Blood & Cancer·Alexander NgwubeShalini Shenoy
Apr 4, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alok KothariShalini Shenoy
Feb 5, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Adam S NelsonParinda A Mehta
Mar 16, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carmem BonfimRicardo Pasquini
Mar 22, 2016·Annals of the New York Academy of Sciences·Shalini Shenoy, Alexis A Thompson
Apr 20, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hyoung Jin KangUNKNOWN Korean Society of Pediatric Hematology-Oncology
May 12, 2016·The New England Journal of Medicine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Current Pharmaceutical Design
Lazaros LekakisMarcos de Lima
Journal of Pediatric Intensive Care
Kathryn WalshChristine N Duncan
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Frederick R Appelbaum
© 2021 Meta ULC. All rights reserved